Skip to main content
Signal8
Launch Terminal
Ainsworth Sean profile photo

Sean Ainsworth

CIK: 0001830296

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Opus Genetics, Inc. logo
IRD

Opus Genetics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • Opus Genetics, Inc. logo
    IRD

    Opus Genetics, Inc.

    Apr 20, 2026
    Award(A)
    Direct
    24.4K shares-
  • Opus Genetics, Inc. logo
    IRD

    Opus Genetics, Inc.

    Jan 1, 2026
    Award(A)
    Direct
    42.5K shares-
  • Opus Genetics, Inc. logo
    IRD

    Opus Genetics, Inc.

    Aug 25, 2025
    Award(A)
    Direct
    87K shares at avg. $1.15$100K
  • Opus Genetics, Inc. logo
    IRD

    Opus Genetics, Inc.

    Apr 30, 2025
    Award(A)
    Direct
    79.5K shares-

1-4 of 4

About Ainsworth Sean

Ainsworth Sean (SEC CIK 0001830296) files insider reports with the SEC as Director of Opus Genetics, Inc. (IRD).

Signal8 holds 4 ownership filings by Ainsworth Sean, all Form 4s, filed between May 2, 2025 and Apr 22, 2026. Those filings report 4 transactions, from Apr 30, 2025 to Apr 20, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Ainsworth Sean's filings is in DURHAM, NC.

Recent filings by Ainsworth Sean

  • Apr 20, 2026: Grant or award of IRD shares (Form 4, code A).
  • Jan 1, 2026: Grant or award of IRD shares (Form 4, code A).
  • Aug 25, 2025: Grant or award of IRD shares (Form 4, code A).
  • Apr 30, 2025: Grant or award of IRD shares (Form 4, code A).

Other insiders filing for Opus Genetics, Inc. (IRD)

How to read Form 4 transaction codes